Neutralizing Antibody Response by Inactivated SARS-CoV-2 Vaccine on Healthcare Workers

Background: Currently, the key to combat coronavirus disease 2019 (COVID-19) as a global pandemic is relying mainly on vaccination, and several factors might affect the level of protection. This study aimed to determine the quantitative increase of neutralizing antibody titer against COVID-19 and th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Nataniel Tandirogang (Egilea), Evi Fitriany (Egilea), Nursaci Mardania (Egilea), Miftahul Jannah (Egilea), Bilqis Faiqotun Nabilah Dilan (Egilea), Sapta Rahayuning Ratri (Egilea), Arfian Deny Prakoso (Egilea), Meiliati Aminyoto (Egilea), Yuliana Kartika Ningrum (Egilea), Ika Fikriah (Egilea), Yadi Yadi (Egilea)
Formatua: Liburua
Argitaratua: Cell and BioPharmaceutical Institute, 2023-03-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2ef726bae6d94dffbcb4df0a34a9c97d
042 |a dc 
100 1 0 |a Nataniel Tandirogang  |e author 
700 1 0 |a Evi Fitriany  |e author 
700 1 0 |a Nursaci Mardania  |e author 
700 1 0 |a Miftahul Jannah  |e author 
700 1 0 |a Bilqis Faiqotun Nabilah Dilan  |e author 
700 1 0 |a Sapta Rahayuning Ratri  |e author 
700 1 0 |a Arfian Deny Prakoso  |e author 
700 1 0 |a Meiliati Aminyoto  |e author 
700 1 0 |a Yuliana Kartika Ningrum  |e author 
700 1 0 |a Ika Fikriah  |e author 
700 1 0 |a Yadi Yadi  |e author 
245 0 0 |a Neutralizing Antibody Response by Inactivated SARS-CoV-2 Vaccine on Healthcare Workers 
260 |b Cell and BioPharmaceutical Institute,   |c 2023-03-01T00:00:00Z. 
500 |a 2527-4384 
500 |a 2527-3442 
500 |a 10.21705/mcbs.v7i1.303 
520 |a Background: Currently, the key to combat coronavirus disease 2019 (COVID-19) as a global pandemic is relying mainly on vaccination, and several factors might affect the level of protection. This study aimed to determine the quantitative increase of neutralizing antibody titer against COVID-19 and the influence of gender, body mass index (BMI), routine consumption of vitamin C, D, and E towards the neutralizing antibodies after vaccination. Materials and methods: One hundred nine health workers from various health facilities were recruited. Sinovac inactivated severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccine was used in this study. Antibody titer measurements were carried out quantitatively using electrochemiluminescence immunoassay (ECLIA) on day 14 after the first and second doses administration of the vaccine. Results: The average of antibody titers after the first and second doses were 109.1 and 191.6 U/mL, respectively. Antibody titer significantly increased (p=0.000) as much as 82.5 U/mL from the first to the second dose. There was a significant difference in the increase in antibody titer between respondents who consumed vitamin E regularly and those who did not (p=0.036). Routine consumption of vitamin C and D, gender, and BMI did not affect the increase in neutralizing antibody titer with p-values of 0.983, 0.337, 0.186, and 0.424, respectively. Conclusion: Routine consumption of vitamin E is associated with post-SARS-CoV-2 vaccination neutralizing antibody response. Gender, BMI, and the routine consumption of vitamin C and D have no association with the immune response. Keywords: COVID-19, neutralizing antibody, inactivated SARS-CoV-2 vaccine 
546 |a EN 
690 |a Pathology 
690 |a RB1-214 
690 |a Biochemistry 
690 |a QD415-436 
655 7 |a article  |2 local 
786 0 |n MCBS (Molecular and Cellular Biomedical Sciences), Vol 7, Iss 1, Pp 18-27 (2023) 
787 0 |n https://cellbiopharm.com/ojs/index.php/MCBS/article/view/303 
787 0 |n https://doaj.org/toc/2527-4384 
787 0 |n https://doaj.org/toc/2527-3442 
856 4 1 |u https://doaj.org/article/2ef726bae6d94dffbcb4df0a34a9c97d  |z Connect to this object online.